| Literature DB >> 32489947 |
Ata Bushehri1, Davood Zare-Abdollahi1, Afagh Alavi1, Alireza Dehghani2, Mohammadreza Mousavimikala3, Hamid Reza Khorram Khorshid1.
Abstract
Homozygous mutations of PROS1, encoding vitamin K-dependent protein S (PS), have been reported so far to be associated with purpura fulminans, a characteristic fatal venous thromboembolic disorder. The current work for the first time reports the clinical phenotype in patients with juvenile retinitis pigmentosa harboring a novel likely pathogenic variant in thePROS1 gene. Whole-exome sequencing was performed on probands of a cohort with inherited retinal disease. Detailed phenotyping was performed, including clinical evaluation, electroretinography, fundus photography and spectral-domain optical coherence tomography. Analysis of whole-exome and Sanger sequencing led to the identification of a homozygous missense substitution (c.G122C:p.R41P) in PROS1 in affected individuals from two unrelated consanguineous families of Persian origin which had classic retinitis pigmentosa with no history of venous thromboembolic disorder. This variant was segregated, fully congruous with the phenotype in all family members. Consistently, none of 1000 unrelated healthy individuals from the same population carried the mentioned variant, according to Iranian national genome database (Iranome) and additional in-house exome control data. This study provides inaugural clinical traces for different role of PS as a ligand for TAM receptor-mediated efferocytosis at the retinal pigmented epithelium; the R41P variant may affect proper folding of PS needed for γ-carboxylation and extra-cellular secretion. That conformational change may also lead to defective apoptotic cell phagocytosis resulting in postnatal degeneration of photoreceptors.Entities:
Keywords: PROS1; RP; Retinitis pigmentosa; TAM receptor; apoptosis; efferocytosis; protein S
Year: 2019 PMID: 32489947 PMCID: PMC7241841 DOI: 10.22088/IJMCM.BUMS.8.3.179
Source DB: PubMed Journal: Int J Mol Cell Med ISSN: 2251-9637
Clinical description of the patients
|
|
|
|
|
|
|---|---|---|---|---|
|
| IDA (9) | NB (11) | NB (early teen ages) | NB (11) |
|
| NA | NA | 5°-10° Central | 10°-20° Central |
|
| OD: LP | OD: LProj | OD: 0.001 (HM@2’) | OD: 0.1 |
|
| VDLP | VDLP | VDLP | VDLP |
|
| PSC | PSC | PSC | PSC |
|
| RCD | RCD | RCD | RCD |
|
| Retinal atrophy | Not performed | Retinal atrophy | Not performed |
|
| Non-recordable | Not performed | Non-recordable | Not performed |
AFR: absent foveal reflex; BCVA: best corrected visual acuity; BSC: bone spicule configuration; CS: central scotoma; CV: color vision; HM: hand motion; IDA: impaired dark adaptation; LProj: recognition of light projection; LP: light perception; NA: not applicable; NB: night blindness; OCT: optical coherence tomography; ODP: optic disc pallor; OD: right eye; OS: left eye; PSC: posterior sub-capsular cataract; RE: refractive errors; RL: RPE loss; RVA: retinal vessels attenuation; TVF: Tunnel visual field; VAD: visual acuity disturbance; VDLP: vitreous dust like particles; VF: visual field; WODP: waxy optic disc pallor;
Fig. 1Pedigree of families, retinal imaging and sequencing electropherograms of PROS1-related RP. a: pedigree chart of family A with R41P PROS1 mutation. Retinal imaging of patient V-10 (proband) from family A. Central fundus photographs of both eyes: visible choroid arteries due to extreme RPE loss, grievous arteriolar narrowing, waxy pallor optic disc, bone-spicule pigmentary changes, reduced foveal reflex, also choroidal folds and visible sclera in nasal quadrant of the left eye are more prominent. Spectral domain optical coherence tomography (SD-OCT) of the macula; right eye: Epi-retinal membrane, retinal fold and cystoids edema of the macula, left eye: normal retinal structure. Results of family A members’ Sanger sequencing electropherograms identifying the missense mutation, c. G122C, are compatible with their phenotypes. b: pedigree chart of family B. Retinal imaging of patient V-4 (proband) from family B; fundus photographs of both eyes: RPE loss, arteriolar narrowing, waxy pallor optic disc, bone-spicule pigmentary changes, and reduced foveal reflex. SD-OCT of both eyes: atrophy of the inner retinal layers in the peripheral macula. Full-field ERG of proband of family A showed an advanced RP pattern of generalized dysfunction: a flat rod-driven response of on bipolar cells (dark-adapted 0.01 ERG); almost undetectable rod dominated combined responses from both photoreceptors and bipolar cells (dark-adapted 3.0 ERG); non-responsive dark-adapted 10.0 ERG with enhanced a-waves reflecting combined photoreceptor function; significantly reduced amacrine cell responses (scotopic 3.0 oscillatory potential ERG); completely extinguished cone-pathway-driven responses on phototopic 3.0 ERG and markedly reduced sensitive light adapted response (30 Hz flicker ERG). Results of family B members’ Sanger sequencing electropherograms
Fig. 2Immunologically silent phagocytosis (efferocytosis) in the retina via PtdSer-PS-Mer signaling. PtdSer-PS-MerTK signaling drives phagocytic pruning of just photoreceptor outer segments by RPE cells on regular basis. Binding of PS (blue) to the Mer (grey and red) receptor is mediated by its sex hormone-binding globulin (SHBG)-like domains through the two immunoglobulin-related domains (Ig1/Ig2) of the Mer receptor. The binding of essential Ca2+ ions (purple) stabilizes the structure of the GLA domain where it detects the head group of phosphatidylserine (PtdSer) (green). Cell1 represents photoreceptors and cell2 represents RPE phagocytic cells
Fig. 3Effect of p.R41P variant on C-terminal residue of the propeptide sequence. a and b: replacement of the highly conserved R -1 by a P (yellow) at last C-terminal residue of the propeptide (PRO), with respective hydropathicity score of -4.500 and -1.600 (https://web.expasy.org/protscale/pscale/Hphob.Doolittle.html/). This substitution affects proper folding of PS (blue) in ER lumen needed for γ-carboxylation and extra-cellular secretion. Proline as the only amino acid that has a secondary amine attached directly to its side chain disrupts the binding of glutamate residues (purple) to the reduced vitamin K (red) at the γ-carboxylase (grey) active site by launching a sharp bend. It also interferes in α-helix formation by steric effects and electrostatic repulsion. c and d: predicted effect of p.R41P variant on the 3D propeptide of PS structure (using PyMOL molecular visualization system software through manual residue building). Close-up structure model of the amino acid position 41 with blue as wild type and yellow/blue representing the p.R41P mutant. The substitution alters the conformation of the connection loop between two α-helices of the propeptide and the N-terminal of the GLA domain (according to predicted secondary structure from I-TASSER Annotation; https://zhanglab.ccmb.med.umich.edu/I-TASSER/output/S423178/). H: helix; C: coil
Conserved 18-amino acid propeptide sequences upstream of human vitamin K-dependent (VKD) proteins
|
| -18 | -17 |
| -15 | -14 | -13 | -12 | -11 |
| -9 | -8 | -7 |
| -5 | -4 | -3 | -2 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| A | N |
| L | S | K | Q | Q |
| S | Q | V |
| V | R | K | R |
|
|
| S | V |
| S | S | S | E | R |
| H | Q | V |
| R | I | R | K |
|
|
| S | L |
| I | R | R | E | Q |
| N | N | I |
| A | R | V | T |
|
|
| T | V |
| L | D | H | E | N |
| N | K | I |
| N | R | P | K |
|
|
| R | V |
| V | T | Q | E | E |
| H | G | V |
| H | R | R | R |
|
|
| H | V |
| L | A | P | Q | Q |
| R | S | L |
| Q | R | V | R |
|
|
| R | V |
| L | T | G | E | K |
| N | S | I |
| K | R | Y | P |
|
|
| N | P |
| I | N | R | R | N |
| N | T | F |
| S | P | Q | Q |
|
|
| K | A |
| V | S | K | Q | E |
| S | E | V |
| K | R | P | R |
|
Highly conserved amino acids (F -16, A -10, L -6 and R -1) are highlighted in yellow.
High degree of similarity of propeptide of PS among vertebrates
|
| -18 | -17 | -16 | -15 | -14 | -13 | -12 | -11 | -10 | -9 | -8 | -7 | -6 | -5 | -4 | -3 | -2 | -1 | Similarity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| A | N | F | L | S | K | Q | Q |
| S | Q | V |
| V |
| K |
|
|
|
|
| A | N | F | L | S | K | Q | Q |
| S | Q | I |
| V |
| K |
|
|
|
|
| A | N | F | F | S | K | Q | Q |
| S | Q | V |
| V |
| K |
|
|
|
|
| A | N | F | L | S | K | Q | Q |
| S | Q | V |
| I |
| K |
|
|
|
|
| T | N | F | L | S | K | E | R |
| S | Q | V |
| V |
| K |
|
|
|
|
| A | N | F | L | S | R | Q | H |
| S | Q | V |
| V |
| R |
|
|
|
|
| D | S | I | L | S | K | Q | Y |
| S | Q | V |
| F |
| K |
|
|
|
|
| A | T | F | L | S | H | Q | Y |
| S | E | F |
| A |
| K |
|
|
|
|
| M | F | L | L | S | Q | Q | Y |
| S | E | F |
| V |
| K |
|
|
|
|
| R | T | F | L | S | P | Q | Y |
| S | E | F |
| N |
| R |
|
|
|
|
| Q | R | F | L | P | Q | S | K |
| S | E | F |
| L |
| H |
|
|
|
|
| Q | H | F | L | Q | Q | S | T |
| L | Q | F |
| A |
| R |
|
|
|
|
| S | L | F | L | G | R | S | S |
| S | Q | F |
| S |
| Q |
|
|
|
Highly evolutionary conserved amino acids (A -10, L -6, R -4, -2 and -1) are highlighted in yellow.